Skip to main content

Amphastar Pharmaceuticals, Inc.

AMPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001297184

In the last 90 days, Amphastar Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 212 institutions reported holding it in 13F filings for Q2 2026, worth $572.1M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Amphastar Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of AMPH: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders2691279+11
Shares34.4M5.94M35.4M+7.01M (+24.7%)
Value$1.37B$237.7M$1.72B+$580.9M (+51.1%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (43)

Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to AMPH in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.6,032,722$292.8M0.01%
Boston Trust Walden Corp539,639$26.2M0.18%
Hotchkis & Wiley Capital Management LLC222,620$10.8M0.04%
Weiss Asset Management LP102,358$4.97M0.13%
Danske Bank A/S80,080$3.89M0.01%
Algert Global LLC66,285$3.22M0.09%
Taika Capital, LP36,775$1.78M1.34%
SG Americas Securities, LLC35,234$1.71M0.01%
Chase Investment Counsel Corp29,000$1.41M0.47%
Chatham Capital Group, Inc.27,690$1.34M0.22%
D. E. Shaw & Co., Inc.23,659$1.15M0.00%
Wellington Management Group LLP19,723$957.2K0.00%
Segall Bryant & Hamill, LLC18,968$920.5K0.01%
Los Angeles Capital Management LLC16,169$784.7K0.00%
XTX Topco Ltd13,891$674.1K0.05%
International Assets Investment Management, LLC22,809$470.0K0.00%
Sterling Capital Management LLC9,319$452.3K0.01%
Hohimer Wealth Management, LLC6,994$339.4K0.07%
BCJ Capital Management, LLC6,617$321.1K0.02%
Gsa Capital Partners LLP6,249$303.0K0.02%
Cornercap Investment Counsel Inc5,421$263.1K0.08%
Cetera Investment Advisers5,237$254.2K0.00%
Brinker Capital Investments, LLC4,919$238.7K0.00%
Orion Portfolio Solutions, LLC4,919$238.7K0.00%
Two Sigma Securities, LLC4,916$238.6K0.02%
Shell Asset Management Co4,850$235.0K0.01%
Xponance, Inc.4,497$218.2K0.00%
Cresset Asset Management, LLC4,363$211.7K0.00%
Retirement Guys Formula LLC4,185$203.1K0.09%
Dakota Wealth Management4,164$202.1K0.00%
Asset Management One Co.,Ltd.1,609$78.1K0.00%
Catalyst Funds Management Pty Ltd800$38.8K0.01%
Acadian Asset Management LLC718$34.0K0.00%
Northwestern Mutual Wealth Management Co200$9.71K0.00%
Truvestments Capital LLC198$9.61K0.00%
Spectrum Wealth Counsel, LLC70$3.40K0.00%
Elequin Capital LP60$2.91K0.00%
Picton Mahoney Asset Management24$1.00K0.00%
Reuter James Wealth Management, LLC20$9710.00%
Voisard Asset Management Group, Inc.14$6800.00%
Capital Performance Advisors LLP11$5340.00%
Legacy Investment Solutions, LLC10$4550.00%
Legacy Wealth Managment, LLC10$4550.00%

Sold out (32)

Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Not filed for Q3 2024 yet (1)

Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AMPH in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.5,942,524$237.7M